Japan Vaccine Development Lead

GSK

Not Interested
Bookmark
Report This Job

profile Job Location:

Tokyo - Japan

profile Monthly Salary: Not Disclosed
Posted on: 9 hours ago
Vacancies: 1 Vacancy

Job Summary

Job Purpose

The Japan Vaccine Development Lead (J-VDL) is accountable for a vaccine development in Japan to ensure delivery differentiated vaccines of value for patients stakeholders and markets in Japan. The J-VDL serves as the asset level point-of-contact for Vaccine Development Leader (VDL) and asset single point of contact to Japan senior management and Japan governance board. JVDL must work closely with VDL not only successful launch for Japan but also overall success for GSK Global as one of the key leaders in Global Vaccine Development Team (VDT).

Key Responsibilities

  • Provide leadership and collaborates with the central Vaccine Development Team (VDT) to create overall integrated development strategies that support optimal medicine development for Global as well as Japan including Integrated Evidence Plan (IEP) and Vaccine Profile. Serves as the asset level point-of-contact for the central Vaccine Development Leader (VDL).
  • Acts as a single point of accountability for all aspects of a vaccine development in Japan from initiation of Japan development to launch in Japan. Provide clinical leadership and asset/disease expertise for the clinical trial program and indications in scope
  • Delivers differentiated vaccines of value for patients stakeholders and markets in Japan on time within budget through an evidence package that supports regulatory approval market access and product life cycle in Japan.
  • Provide Matrix Leadership in Japan (i.e. Japan Vaccine Development Team) to ensure integrated approach robust planning and execution oversight. Also supports differentiated development for team members; owns the performance of J-VDT and partners with line managers to drive performance. Serves as the single accountable decision maker to resolve disputes among the J-VDT.
  • Works closely with the Japan Early Development Leader (J-EDL) as well as Japan Medical Lead (J-MAL) and Japan Commercial Lead (JCL) to ensure a smooth transition between the J-EDL (accountable from C2CS to initiation of Japan development) to J-VDL (accountable from initiation of Japan development to the first approval in Japan) and from J-VDL to J-MAL/JCL (accountable after the first approval in Japan).
  • Asset single point of contact and spokesperson to Japan senior management and Japan governance board (e.g. Portfolio Investment Board Japan).
  • Proactively identifies unmet medical needs that could be addressed through line extensions in Japan. Prioritizes and maximizes the assets portfolio options including developing multiple indications in Japan.
  • Responsible for making recommendations to TAL/IET Leader and senior stakeholders on benefit risk assessment Go/No-go criteria and Clinical PoS for the program in scope
  • To create the communication strategy and represent GSK externally and keep good relationship with Regulatory and government organisations
  • Ministry of Health Labor and Welfare PMDA
  • Japanese Government (Cabinet minister Minister office)
  • National Center Researech Institute (National Cancer Hospital etc) Scientific Societies EEs
  • Patient Groups
  • CROPPD
  • Ensures quality & compliance oversight in line with R&D expectations and project needs; assures quality of data and science. Ensures excellence in execution of all governance processes including oversight of all studies pharmacovigilance scientific engagement and promotional practices.
  • J-VDL is accountable for delivering and managing the asset resourcing plan in addition the J-VDL is accountable for managing the asset budget in Japan.

Minimum Level of Job-Related Experience & education

  • Master of Science or equivalent.
  • MD PhD PharmD preferred
  • Vaccine development experience in the Japan market preferred
  • Considerable pharmaceutical industry experience is required
  • Filing experience JNDA as a core responsibility and have led development programs and deep experience in all phases of product development especially in late phase development is preferred
  • Experience of working with Japan regulators and regulatory requirements including an understanding of the legal and government frameworks
  • High-business level Japanese and English

Why GSK

Uniting science technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade as a successful growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory immunology and inflammation; oncology; HIV; and infectious diseases to impact health at scale.

People and patients around the world count on the medicines and vaccines we make so were committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients accountable for impact and doing the right thing is the foundation for how together we deliver for patients shareholders and our people.

We are committed to creating an inclusive workplace and providing equal opportunities for all applicants. We embrace an agile working culture across our roles so if flexibility is important to you please discuss opportunities with our hiring team. If you need any adjustments to the recruitment process to help you demonstrate your strengths and capabilities contact . Please note this email is for adjustment requests only; for other enquiries please use our standard contact channels.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSKs commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Job PurposeThe Japan Vaccine Development Lead (J-VDL) is accountable for a vaccine development in Japan to ensure delivery differentiated vaccines of value for patients stakeholders and markets in Japan. The J-VDL serves as the asset level point-of-contact for Vaccine Development Leader (VDL) and as...
View more view more

Key Skills

  • Administrative Skills
  • Facilities Management
  • Biotechnology
  • Creative Production
  • Design And Estimation
  • Architecture

About Company

Company Logo

About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

View Profile View Profile